Opens in a new tab

Positive FIT Test? Why Your Follow-Up Colonoscopy Can't Wait

Table of Content

Home FIT test kit and colonoscopy appointment on a calendar after a positive FIT test result

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

A positive stool test for colon cancer is only half of a screening. The other half is a follow-up colonoscopy, and new research shows that many people never get one. In a review of 21 studies published in JAMA Internal Medicine and covered in the medical press this week, fewer than half of patients with an abnormal stool test went on to have a colonoscopy when no extra help was offered. With simple support, such as reminders or a staff member who helps with scheduling, that share rose to about 7 in 10.

If you have just received a positive FIT test result, this article explains what the new research found, how long is too long to wait, and what helps people complete the second step.

What the new research found

The FIT test (fecal immunochemical test) looks for tiny amounts of human blood in a stool sample. It is done at home, once a year, and US guidelines recommend colorectal cancer screening for most adults aged 45 to 75. The CDC and the American Cancer Society are clear on one point: if a stool test is abnormal, a colonoscopy is needed to complete the screening process.

The JAMA Internal Medicine meta-analysis, led by researchers in Singapore with a co-author from Duke University, pooled data from 19,613 adults aged 50 to 75 who had an abnormal FIT or older fecal occult blood test. Its main findings:

  • Without a dedicated follow-up program, only about 48% of patients completed their colonoscopy.
  • With follow-up programs, completion reached about 69%.
  • Four approaches worked: patient navigation, reminders sent to patients, reminders sent to clinicians and automatic referral to a gastroenterologist.

A second systematic review, published the same day in BMJ Open, found the same pattern across 25 studies. Completion within 6 to 12 months ranged from roughly 30% to 55% in community and safety-net health centers, but reached 70% to 80% or more in organized programs that track every abnormal result. Waiting times ranged from about 6 weeks to 6 months.

The message is not that stool tests fail. They work well when the full pathway is completed. Our earlier article on how stool tests cut colon cancer deaths explains that benefit, and why a positive result is not a cancer diagnosis.

How long is too long to wait?

There is no single official deadline in the US. A 2026 review of 18 guidelines in the Journal of General Internal Medicine found that the few guidelines defining "timely" follow-up set it between 56 and 180 days after a positive stool test. The same review reported that the chance of finding cancer rises when the colonoscopy happens more than 180 days after the test.

A population study from Alberta, Canada, that followed more than 63,000 people with a positive FIT found that the risk of colorectal cancer, especially advanced-stage cancer, was clearly higher when the colonoscopy took place more than 12 months after the test.

In practical terms, ask for your colonoscopy to be booked as soon as you get the result, and aim to have it done within a few weeks to a few months, not a year.

What actually gets people to their colonoscopy

The barriers are often practical: not knowing who should order the colonoscopy, fear of the bowel preparation, transportation, time off work or cost worries. The table below summarizes what the 2026 meta-analysis measured for each type of support.

Type of supportWhat it meansEffect on colonoscopy completion
Patient navigationA trained person explains the result, books the procedure and helps with the bowel prepAbout 24% more people completed it
Patient remindersCalls, letters or text messagesAbout 32% more
Clinician remindersAn alert in the medical record for the doctorAbout 36% more
Automatic referralThe abnormal result triggers a gastroenterology referralAbout 68% more, but results varied widely between studies

A randomized trial in North Carolina community health centers, published in 2026, showed what navigation looks like in real life: 69% of navigated patients completed their colonoscopy within a year, compared with 39% with usual care, and they got it done about 80 days sooner on average.

Outreach also matters before the test. A trial in 16 San Diego community health centers, published in JAMA Network Open and reported this week, found that mailing FIT kits with reminders raised screening rates for two years, although the gap with usual care was no longer significant in year three. Screening only helps if each step, from the kit to the colonoscopy, is completed.

Which tests can monitor or screen for this?

  • FIT test: checks stool for hidden human blood, once a year. A positive result needs a colonoscopy.
  • Stool DNA test with FIT (multitarget stool DNA): looks for blood and abnormal DNA. A positive result also needs a colonoscopy.
  • Colonoscopy: the reference exam, which can find and remove polyps during the same procedure.
  • Complete blood count and ferritin: slow, hidden bleeding from the gut can show up as anemia or a low ferritin level. In an adult over 45, unexplained iron-deficiency anemia deserves a look at the digestive tract.
  • Blood-based colon cancer tests: newer options exist, but they do not replace a colonoscopy after a positive stool test. See our article on the colon cancer blood test.

Other causes of blood in stool, such as hemorrhoids, can make a FIT positive. Only a colonoscopy can tell the difference, so a positive result should never be explained away without one.

Latest scientific advances, in plain language

  • Follow-up is now measured as carefully as screening itself. Researchers are pushing for a standard deadline and a clear target for how many people should complete their colonoscopy, so health systems can be compared and improved.
  • The weak link is organization, not the test. Programs that track every abnormal result, name a person responsible and help with scheduling do much better.
  • Low-cost tools work. Phone calls, text reminders and help with booking raise completion without expensive technology.
  • Inequalities are a focus. A 2026 meta-analysis of studies in underserved communities found that patient navigation increased completion of the follow-up colonoscopy.

When to see a doctor

  • Your stool test is positive and nobody has contacted you about a colonoscopy within one to two weeks: call the office that ordered the test.
  • You see blood in your stool, have black stools, a lasting change in bowel habits, belly pain or unexplained weight loss, even if a recent stool test was negative.
  • Your blood test shows iron-deficiency anemia or low ferritin without a clear explanation.
  • You have a parent, brother or sister with colorectal cancer: you may need a colonoscopy rather than a stool test, and earlier.

Glossary

  • FIT (fecal immunochemical test): a home stool test that detects human blood using antibodies.
  • Colonoscopy: an exam with a thin camera that looks at the whole colon and can remove polyps.
  • Polyp: a growth on the lining of the colon. Some types, called adenomas, can turn into cancer over years.
  • Patient navigation: help from a trained person who guides a patient through each step of care.
  • Meta-analysis: a study that combines the results of many studies to get a more reliable answer.

Frequently asked questions

Does a positive FIT test mean I have cancer?

No. It means blood was found in the stool. Most people with a positive FIT do not have cancer. Many have polyps, which can be removed during the colonoscopy, and some have harmless causes of bleeding.

Can I just repeat the FIT test instead of having a colonoscopy?

No. The CDC and the American Cancer Society state that an abnormal stool test must be followed by a colonoscopy. A negative repeat test does not cancel the first positive result.

How soon should I have my colonoscopy after a positive FIT?

As soon as it can be arranged. Guidelines that set a deadline range from about 2 to 6 months, and studies link delays beyond 6 to 12 months with a higher chance of finding cancer, including advanced cancer.

What if I am afraid of the bowel preparation?

Tell your care team. Fear of the prep is a common reason people skip the exam. Many offices can explain the steps, adjust the schedule and answer questions, which is exactly what patient navigation does.

Does a stool DNA test work the same way?

Yes, for this question. A positive stool DNA test also needs a follow-up colonoscopy to complete screening.

Sources

Further reading

Understand your own blood test results with AI DiagMe

A low ferritin level or a borderline hemoglobin can be the first clue to slow bleeding in the gut. Upload your blood test report to AI DiagMe and get a clear, plain-language explanation of each result, with the questions worth asking your doctor. Analyze my blood test with AI DiagMe

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr. Claude Tchonko is a hematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specializes in the management of hematologic malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimization of care pathways in onco-hematology.

    Author of a reference work, “Lymphoid Hematologic Malignancies in Mali”, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Hematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Hematology and an inter-university diploma (DIU) in Onco-Hematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming Soon